Inventor · disambiguated record
John Eksterowicz
Also filed as: EKSTEROWICZ JOHN
22 granted patents·14 pending applications·87 citations·filing 2008–2025
94Inventor score
Top patents by PatentIndex Score
36 records- 0196US11028120B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2020·Granted Jun 8, 2021·10 cites·30 claims
- 0295US12018043B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2022·Granted Jun 25, 2024·6 cites·33 claims
- 0395US11130778B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2021·Granted Sep 28, 2021·8 cites·30 claims
- 0494US11530236B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2020·Granted Dec 20, 2022·4 cites·25 claims
- 0593US11325938B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2020·Granted May 10, 2022·9 cites·20 claims
- 0691US11129841B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2018·Granted Sep 28, 2021·7 cites·20 claims
- 0790US10472387B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2019·Granted Nov 12, 2019·2 cites·6 claims
- 0888US11377469B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2018·Granted Jul 5, 2022·5 cites·19 claims
- 0988US9593129B2Piperidinone derivatives as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2016·Granted Mar 14, 2017·5 cites·18 claims
- 1088US9296736B2Piperidinone derivatives as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2014·Granted Mar 29, 2016·7 cites·13 claims
- 1187US12454544B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2024·Granted Oct 28, 2025·0 cites·9 claims
- 1287US2024300892A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2023·Application pending·0 cites
- 1386US11576922B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2021·Granted Feb 14, 2023·1 cites·41 claims
- 1486US9376425B2Heterocyclic compounds as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2012·Granted Jun 28, 2016·12 cites·37 claims
- 1585US11807658B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2022·Granted Nov 7, 2023·1 cites·19 claims
- 1683US2025368677A1Cd73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1780US8841312B2Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitorsCONNORS RICHARD V·Filed 2008·Granted Sep 23, 2014·6 cites·35 claims
- 1880US2022169611A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2022·Application pending·0 cites
- 1979US11124537B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2016·Granted Sep 21, 2021·1 cites·23 claims
- 2076US10723759B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2019·Granted Jul 28, 2020·0 cites·28 claims
- 2176US2023096870A1Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2276US2024124512A1Cd73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2375US8389533B2Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitorsCONNORS RICHARD V·Filed 2009·Granted Mar 5, 2013·3 cites·20 claims
- 2474US2021179560A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2020·Application pending·0 cites
- 2570US10836789B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2020·Granted Nov 17, 2020·0 cites·30 claims
- 2669US2021017219A1Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2767US2022259253A1Cd73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2867US2019062276A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2018·Application pending·0 cites
- 2964US2021379084A1Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3064US2017144971A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2017·Application pending·0 cites
- 3161US2021395295A1Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3259US11110103B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2016·Granted Sep 7, 2021·0 cites·12 claims
- 3354US8980903B2Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitorsAMGEN INC·Filed 2014·Granted Mar 17, 2015·0 cites·22 claims
- 3446US2021122730A1Glucocorticoid receptor modulatorsORIC PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3544US2022079924A1Glucocorticoid receptor modulatorsORIC PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3642US11208432B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2016·Granted Dec 28, 2021·0 cites·35 claims
Join the waitlist — get patent alerts
Get an alert when John Eksterowicz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →